𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis

✍ Scribed by Panagiotis Kamperidis; Tahereh Kamalati; Mathieu Ferrari; Margaret Jones; Toby Garrood; Malcolm D. Smith; Soraya Diez-Posada; Chris Hughes; Ciara Finucane; Stephen Mather; Ahuva Nissim; Andrew J. T. George; Costantino Pitzalis

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
409 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Potentiation of photodynamic therapy in
Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-Ξ±
✍ David A. Bellnier πŸ“‚ Article πŸ“… 1991 πŸ› Elsevier Science 🌐 English βš– 590 KB

The tumoricidal response of subcutaneously growing SMT-F adenocarcinoma implanted into syngeneic DBA/2 mice to Photofrin II-sensitized photodynamic therapy (PDT) was statistically significantly enhanced by the addition of a single dose of intravenously administered recombinant human tumor necrosis f

Development of a novel indwelling balloo
Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy
✍ Steen J. Madsen; Chung-Ho Sun; Bruce J. Tromberg; Henry Hirschberg πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 152 KB πŸ‘ 1 views

## Abstract ## Background and Objective A human glioma spheroid model is used to investigate the efficacy of different light delivery schemes in 5‐aminolevulinic acid (ALA)β€”mediated photodynamic therapy (PDT). The results provide the rationale for the development of an indwelling balloon applicato

Targeting an extracellular epitope of th
Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody
✍ Liat Binyamin; Yehuda G. Assaraf; Maya Haus-Cohen; Michal Stark; Yoram Reiter πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 305 KB πŸ‘ 1 views

## Abstract Inherent and acquired multidrug resistance (MDR) is characterized by a simultaneous resistance to diverse anticancer drugs and is a major impediment towards curative chemotherapy of cancer. Hence one important goal is to develop strategies aimed at specific targeting of major anticancer

Angiotensin II type 1 receptor as a nove
Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis
✍ A. Price; J. C. Lockhart; W. R. Ferrell; W. Gsell; S. McLean; R. D. Sturrock πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

## Abstract ## Objective Angiotensin II (Ang II) is known to have proinflammatory actions, and Ang II type 1 (AT~1~) receptors are up‐regulated in the rheumatoid synovium, suggesting that this receptor could be a therapeutic target. The purpose of this study was to investigate the antiinflammatory